The American Herbal Products Association is planning a hemp/CBD event in August in Colorado for dietary supplement companies interested in the ingredient.
Relevium Technologies, a Canadian development stage company focusing on online sales of dietary supplements and personal care products, is moving to acquire LifeLine Pharma, a Colombian cannabis company.
Australia's first trial to test the effects of CBD (cannabidiol) oil on individuals suffering from post-traumatic stress disorder (PTSD) will feature Bod Australia's proprietary CBD oil, MediCabilis.
Colorado has convened a commission to formulate an agricultural plan for the cultivation of industrial hemp in the state. A longtime supplement and natural foods industry consultant is among the participants.
Oregon Sen. Ron Wyden has put further pressure on FDA with a letter requesting a formal announcement of enforcement discretion on the CBD question while a more permanent regulatory solution is hashed out.
An amendment advocated by the Natural Products Association that would earmark funds for CBD regulation was including in the final version of the 2019 appropriations bill passed by the US House of Representatives.
Supplementation with a hemp-derived, CBD-rich extract for six weeks led to significant improvements in sleep and reductions in appetite, according to results of a randomized clinical trial in healthy adults.
Natural products online marketplace Thrive Market has temporarily halted sales of hemp-derived CBD products after its merchant processor demanded it cease selling them amid uncertainty over their legal status, but says it is in conversations with a new...
Congress should act to create a new law to solve the CBD (cannabidiol) regulatory issue, while simultaneously “closing long-standing gaps” in the oversight of all dietary supplements, according to a new paper by Dr Pieter Cohen and Dr Joshua Sharfstein.
US Rep. Jerry McNerney (D-CA) last week filed an amendment to modify the House Agriculture appropriations bill to include critical funds that would enable FDA to undertake the appropriate processes and set a safe level of CBD.
Editor's Spotlight: Notes from Nutrition 2019 in Baltimore, June 8-11
Is there a role for cannabis and its derivatives to play in our food system, perhaps as part of a healthy, well-balanced diet? Scientists explored the question at the recent Nutrition 2019 conference in Baltimore.
Nutrasource Pharmaceutical and Nutraceutical Services (Nutrasource) has merged its third-party certifications into a new brand called Certifications by Nutrasource.
Lessons learned from the history of the dietary supplement industry can be applied to the hemp world, and the blitzkrieg-like pace of the industry means we’ll know in short order who’s getting the message and who isn’t. It will also put pressure on regulators...
Hemp startup Exactus says it is leveraging the agricultural expertise in its management team to secure high quality raw material with a new planting in Oregon.
Betting on the endocannabinoid system is proving a fruitful differentiation strategy as longtime omega-3 brand Omax Health seeks to stand out in a crowded and maturing market.
Pet owners are more likely to support the legalization of marijuana than the overall population, according to a recent Packaged Facts survey. They’re also more likely to agree that both prescription and OTC hemp, CBD, and cannabis products should be legal.
Presentations at the recent FDA meeting on CBD outlined the concerns some academics in the field have about the quality and safety of the products that are on the market.
Friday’s public meeting was an illuminating day of presentations, with multiple viewpoints and interests being aired. On the dietary supplements side, there were strong calls for companies to take the front door with the Agency.
Researchers in Israel reported that participants in a dieting study who showed greater Body Mass Index (BMI) decreases had higher potassium intakes than those with modest BMI decreases.
When it comes to legally marketing conventional food and dietary supplements with CBD and other cannabis-derived compounds, FDA and industry appear stuck in a catch-22.
Gaia Herbs, a leading brand of botanical supplements in terms of sales with distribution in national chains like CVS and Whole Foods Market, has started sales for its full spectrum hemp extract line on its website and will roll out across natural and...
Early returns from the FDA meeting on CBD regulation give a glimpse of the complexity of the regulatory questions, which might stretch the timeline for a new legal framework to extent beyond which many in the industry would find acceptable.
“If we do not succeed in working together to reassure the card brands that they can safely support our industry, then we predict a significant decrease in CBD sales within the next few months,” the National Cannabis Industry Association (NCIA) has warned.
Emerald Health Bioceuticals is building out its endocannabinoid-targeting supplement line with a new emulsified product combining omega-3 fish oils, hemp seed oil and MCT oil from coconut.
A study published recently has found a level of liver toxicity for CBD, putting up a big caveat to the notion within the hemp/CBD world that its products have nothing in the way of safety concerns.
Neptune Wellness Solutions has moved into the CBD field in the United States in a big way with the acquisition of North Carolina hemp products producer SugarLeaf Labs.
We’re no longer in the ‘Wild West’ when it comes to hemp-derived CBD, but buyers can still get burned if they don’t do their homework, says Colorado-based BBB Labs, which has launched a quality assurance seal for its hemp extracts to reassure partners...
Despite comments made by then FDA Commissioner Scott Gottlieb to the contrary, the US Food and Drug Administration does not have a policy of enforcement discretion with respect to products derived from cannabis and its components, including cannabidiol...
The European Industrial Hemp Association (EIHA) has described regulatory measures taken against CBD-containing products as “disproportionate and senseless,” in moves that have bought “negative consequences”.
Australian bio-pharmaceutical firm MGC Pharmaceuticals is eyeing expansion in East and South East Asia with its cannabis-based nutraceutical products, after having recently launched in China.
A data firm specializing in the cannabis markets predicts the US hemp category could grow more than tenfold by 2024, attendees at a recent event were told.
Fundamental questions of identity and intended use will have to be answered before CBD can take center stage as a legal dietary ingredient. The upcoming meeting with FDA will likely provide a start, but hopes that all issues will be quickly solved seem...
The omega-3s market is flourishing, with new combination products driving the growth and a newfound appreciation of the science among consumers and healthcare professionals, an expert says.
Struggling retailer GNC reported first quarter 2019 earnings that included an ‘unexpected decrease in revenue’ from its new China ecommerce joint venture.
Constellation Brands has pivoted out of a smaller ingredient category—polyphenols—and into a much larger one —cannabis. Eyebrows were raised last week when the company projected that Canopy Growth, the cannabis grower that Constellation invested heavily...
Neptune Wellness Solutions has completed a radical refocus of the company with the announcement of its entry into the hemp/CBD market in the United States.
CBD firm Bod Australia has embarked on a first-of-its-kind clinical trial on medical cannabis for Tourette syndrome patients, while continuing to expand its supplements business in countries with a more conducive regulatory environment than its home market.
The hemp/CBD industry is being threatened by so-called synthetic cannabinoids that are flooding the market, attendees at a recent botanicals conference were told.
“Our board sees wisdom in admitting as CRN members those CBD companies who are playing by [the] rules," says CRN president and CEO
Having some companies specializing in the still-not-legal dietary ingredient CBD join CRN will help the trade group as it looks to “help FDA, or Congress, craft those regulations,” said Andrew Shao, CRN’s senior vice president of scientific and regulatory...
Setting firm commodity prices will be one brick in the wall of a fully legitimized hemp industry. One company has set about doing so with a proprietary trading platform.
FDA has reiterated its enforcment stance on CBD and hemp products, has updated a Q&A document on the subject and has specified what kind of information it is seeking in the runup to a public meeting on the subject in May, all as part of documents...
FDA has sent three companies marketing CBD products warning letters over disease claims. The warnings are the first issued under FDA’s de facto ‘enforcement discretion’ policy, which will be discussed at a meeting on CBD set for the end of May.
The hemp industry is advancing so rapidly that the timeline of decades of other sectors is being compressed into just years, attendees at a recent trade show were told.
The world of hemp and CBD products sits at a critical moment in its history, much as the dietary supplement industry did a quarter century ago, according to one of the experts who was there at the birth of the industry.
The American Herbal Products Association (AHPA) has adopted a Guidance Policy for dietary supplement and food products that contain hemp and hemp-derived cannabidiol (CBD).
The European cannabidol (CBD) market is set to blossom over the next four years, according to a market intelligence firm, who also predict that Germany’s growth will outpace that of other EU countries.
